arrow
V

Vasileios Oikonomou

National Institute of Allergy and Infectious Diseases
H指数:25
被引数:5,370

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Local albumin excess exacerbates Candida albicans-induced inflammasome activation linked with hyperinflammation during vulvovaginal candidiasis

局部白蛋白过剩加剧外阴阴道假丝酵母菌病期间假丝酵母菌诱导的炎症小体激活,并与过度炎症相关

2026-10-290
OAAI
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease
2024-10-294
OA
A deep intronic splice-altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion
2024-09-181
PRE
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
2023-08-126
PRE
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
2022-11-1511
OAAI
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2
2022-10-2811
OA
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

儿童和儿科新型冠状病毒肺炎多系统炎症综合征的免疫病理特征

2022-02-17161
OA
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
2022-01-1810
OAAI
Response to Comments on Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
SCIENCE
IF45.8
2021-09-1714
OA
An immune-based biomarker signature is associated with mortality in COVID-19 patients
2021-01-11249
OA